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ABSTRACT 38 
The aim of the present study was to investigate the suitability of the Phase-Rectified Signal Averaging (PRSA) method for 39 
improved risk prediction in cardiac patients. Moreover, this technique, which separately evaluates acceleration and deceleration 40 
processes of cardiac rhythm, allows the effect of sympathetic and vagal modulations of beat-to-beat intervals to be characterized. 41 
Holter recordings of idiopathic dilated cardiomyopathy (IDC) patients were analyzed: high-risk (HR), who suffered sudden 42 
cardiac death (SCD) during the follow-up; and low-risk (LR), without any kind of cardiac-related death. Moreover, a control 43 
group of healthy subjects was analyzed. PRSA indexes were analyzed, for different time scales T and wavelet scales s, from RR 44 
series of 24h-ECG recordings, awake periods and sleep periods. Also, the behavior of these indexes from simulated data was 45 
analyzed and compared with real data results. Outcomes demonstrated the PRSA capacity to significantly discriminate healthy 46 
subjects from IDC patients and HR from LR patients on a higher level than traditional temporal and spectral measures. The 47 
behavior of PRSA indexes agrees with experimental evidences related to cardiac autonomic modulations. Also, these parameters 48 
reflect more regularity of the autonomic nervous system (ANS) in HR patients. 49 
 50 
1. Introduction 51 
Heart rate changes on characteristic time-scales can be associated with regulatory actions of different branches of the 52 
autonomic nervous system (ANS). As it is known, heart rate variability (HRV) is affected by both vagal and sympathetic 53 
modulation of the sinus node. Autonomic dysfunction is closely related to cardiac mortality and susceptibility to life-threatening 54 
arrhythmic events[1]. Consequently, assessment of HRV has been proposed for risk prediction.  55 
Due to the complex interaction between the autonomic control system and several regulatory mechanisms of heart rate, and 56 
the fact that many biological systems have an intrinsically nonlinear behavior, it is reasonable to assume that the control system 57 
regulating the heart is affected by several nonlinear variables[2]. In fact, some evidences suggest that nonlinear methods may 58 
provide supplementary information about various physiological systems involved in cardiovascular pathology[3] and may be 59 
superior predictors of cardiac dysfunction, including ventricular tachycardia and sudden cardiac death (SCD)[4,5], when 60 
compared to traditional time-domain and frequency-domain analyses. Because of this, there has been an increasing emphasis on 61 
applying nonlinear analyses to characterize the variability in cardiovascular processes, including the use of detrended fluctuation 62 
analyses, approximate entropy, sample entropy, Poincaré plots and symbolic dynamics[6,7]. 63 
Since the incidence and progression of heart failure are associated with an increasing severity of autonomic disorders, 64 
specifically a compensatory increase in activity of the sympathetic nervous system and decrease in activity of the 65 
parasympathetic or vagal nervous system[8,9], it is interesting to separately evaluate both branches of ANS. Over the past 66 
decades, power spectral analysis of HRV signals has become a commonly used tool for assessing the effect of sympathetic and 67 
 3
vagal modulations of RR intervals in a non-invasive manner[10-12]. However, this analysis does not always provide reliable 68 
results, because HRV signals are often contaminated by noise and artifacts and spectral analysis does not take into account the 69 
aforementioned intrinsic nonlinear behavior of the system. Nevertheless, an approximate distinction of the effects of vagal and 70 
sympathetic factors might be made possible by the Phase-Rectified Signal Averaging (PRSA) method[13] that offers the 71 
possibility to carry out the selective analysis of acceleration-related and deceleration-related behavior of heart rate. PRSA 72 
algorithm is a nonlinear signal transformation, robust against artefacts and ectopic beats since it is able to extract periodicities 73 
and quasi-periodicities from complex signals[13,14]. This technique might provide more differentiated insights into nonlinear 74 
mechanisms involved in ANS regulation. 75 
The aim of this study is threefold. The first is to apply the PRSA technique in order to investigate its suitability for improving 76 
risk prediction in cardiac patients from 24h-ECG recordings. Since idiopathic dilated cardiomyopathy (IDC) is a common and 77 
largely irreversible form of heart muscle disease[15], a group of IDC patients was analyzed and compared with a control group. 78 
The second is to characterize differences on sympathetic and vagal effects of beat-to-beat intervals by PRSA indexes derived 79 
from 24-hour Holter recordings in healthy subjects and IDC patients with high and low-risk of suffering SCD. And the third is to 80 
evaluate acceleration and deceleration patterns during awake and sleep periods. In order to delve into this issue, besides 81 
analyzing the experimental signals, the proposed methodology has been applied to simulated signals. 82 
  83 
2. Materials and Methods 84 
2.1 Analyzed Data and Pre-Processing 85 
The analyzed experimental data set belongs to the IDEAL database[16]. Two groups of subjects have been selected for the 86 
present study, 62 healthy subjects (NRM) and 42 patients with IDC. Furthermore, two groups of IDC patients have been 87 
analyzed: 30 low-risk patients (LR), without any kind of cardiac-related death in the 3 years following the ECG recording, and 88 
12 high-risk patients (HR), who suffered SCD during the follow-up after the ECG recording. The characteristics of the subjects 89 
included in the study are shown in Table I. Besides demographic characteristics, etiological aspects including the percentage of 90 
patients with ventricular tachycardia (VT) and the left ventricular ejection fraction (LVEF) are shown in that table. Furthermore, 91 
data related to possible comorbidities of the patients and their medication has been included. All subjects gave their written 92 
informed consent before study participation. 93 
The RR intervals, time interval between consecutive heart beats of normal sinus rhythm, of the subjects were obtained from 94 
digital three-orthogonal-lead 24-hour Holter recordings with a sampling frequency of 200Hz[17]. All analyzed subjects had less 95 
than 100 ectopic beats[18]. Therefore, a possible alteration of the results due to a filter procedure can be discarded. In this way, 96 
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RR time series were filtered by replacing artifacts or ectopic beats if they deviated more than a programmed tolerance of 15% 97 
from the mean values of the previous five beats[19,20].  98 
Besides that, the influence of awake and sleep periods on the results has been investigated to get more detailed information 99 
about acceleration and deceleration patterns. Sleep periods correspond, approximately, to the time interval from 12:00a.m. to 100 
6:00a.m. Meanwhile, awake periods were chosen, approximately, from 9:00a.m. to 9:00p.m. 101 
Two types of simulated data were considered: Gaussian white noise (GWN) and autoregressive (AR) processes. GWN was 102 
utilized to simulate a fully unpredictable process; it was generated from series of pseudo-random numbers with null mean and 103 
unit standard deviation. Second-order AR processes driven by GWN were utilized to simulate partially predictable processes. 104 
Two different AR processes were obtained; one of them was shaped to have a power spectrum peak with central frequency at 105 
0.275Hz (HF band) and the other with central frequency at 0.0975Hz (LF band). Both AR processes were designed with a pair of 106 
complex and conjugated poles with modulus ρ=0.98. These processes will be indicated as ARHFc and ARLFc, respectively. Fifty 107 
realizations of 100000 samples were considered for each type of process. 108 
 109 
2.2 Analysis of the HRV 110 
The PRSA technique, proposed by Bauer et al.[13], was applied to characterize acceleration and deceleration processes of 111 
beat-to-beat intervals. The details of the analysis are reported in the Supplementary Data. 112 
Increase and decrease in heart rate are detected over two time scales: time scale T, used to determine the window size for 113 
comparing heart rates, and wavelet scale s. In this study, PRSA waveforms for T={1,…,150} were computed and acceleration 114 
and deceleration capacities (AC and DC, respectively) for s={1,…,150} were calculated. Moreover, the length of the windows 115 
around each anchor (2L) had to be selected. Different values of L were tested, L={5,50,150,500} samples. The analysis requires 116 
to determine the values of T and s that provide the best statistical diagnosis values of AC[T,s] and DC[T,s]. The selection of the 117 
best parameters was done for each analyzed case (NRM vs.IDC and HR vs.LR from 24h-ECG recordings, awake periods and 118 
sleep periods). Moreover, the indexes AC[1,2] and DC[1,2], proposed by Kantelhardt et al.[14], were evaluated for all analyses.  119 
In addition to AC and DC measures, the range of excursion of PRSA waveforms (acceleration excursion, AE[T], and 120 
deceleration excursion, DE[T]) and areas under acceleration and deceleration curves (AA[T] and DA[T]) for each selected optimal 121 
value of T were calculated. These indexes are defined in Fig. 1. 122 
The standard temporal and spectral HRV measures were also calculated according to Task Force guidelines[21]. The 123 
following HRV time-domain measures were obtained: mean of the RR intervals (meanRR) and standard deviation of the NN 124 
intervals (SDNN). Furthermore, power spectra were calculated and the following normalized indexes were obtained: HFn, in 125 
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high frequency band (0.15-0.4Hz); LFn, in low frequency band (0.04-0.15Hz); and VLFn, in a very low frequency band (0.003-126 
0.04Hz). Moreover, the ratio between low frequency and high frequency power (LF/HF) was calculated. 127 
 128 
2.3 Statistical Analysis 129 
The Mann-Whitney U test, a non-parametric test, was used to statistically analyze differences between the groups of subjects: 130 
NRM vs.IDC and LR vs.HR. The statistical significance level was assumed at p-value<0.05 in all the analysis. Pearson 131 
correlation coefficient (ρ) was calculated between PRSA indexes (AC and DC) and SDNN, since this last diagnostic parameter is 132 
clinically relevant.  133 
Owing to the relatively small number of patients with SCD to establish differentiated training and test groups, the results 134 
obtained in the present study should be considered exploratory. In this way, for the classification of the subjects in the groups, a 135 
quadratic discriminant function was performed on each index and the leave-one-out cross-validation technique was applied for 136 
validation. The function was estimated on all-but-one- observation of the data, and then the estimated function was used to 137 
forecast the remaining observation. This procedure was repeated for each proposed index and the number of subjects correctly 138 
classified was assessed by means of the following diagnostic test indexes: sensitivity (sen) and specificity (spe). In addition, 139 
Receiver Operator Characteristic curves (ROC) were constructed and the Area Under the ROC Curves (AUC) calculated with a 140 
95% confidence interval (CI), whereby significance was inferred from a lower bound above AUC=0.5. 141 
 142 
3. Results 143 
3.1 Analysis of Parameters: [T,s] and L 144 
Results of the window length test showed that both AC and DC indexes have very little dependence on L value, lower than 145 
0.01%. From this observation, the parameter L=150 samples was chosen; that is, surroundings of 2L=300, which corresponds to 146 
intervals of approximately five minutes and includes almost all frequency bands of the RR signal according to Richardson et 147 
al.[10]. Furthermore, for both PRSA indexes (AC and DC), those [T,s] values which showed the best compromise between 148 
sensitivity and specificity in discriminating groups and, at the same time, provided a significant p-value, were chosen as the 149 
optimum ones. Fig. 2 shows the AUC for AC and DC, depending on T and s values, from 24h recordings when comparing NRM 150 
vs. IDC. The highest values of AUC are located on low T and low s regions, although there are high AUC values for high T 151 
values and low s values, as well. 152 
Since AC[T,s] and DC[T,s] responses are nearly symmetric, only DC responses are shown for different analyzed RR series and 153 
for simulated signals (Fig. 3 and 4, respectively). 154 
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In Fig. 3, it is shown the behavior of DC as a function of s value for three different values of T={1,5,20}. This behavior 155 
corresponds to the analysis of 24-hour, awake and sleep periods of one subject of each NRM, LR and HR analyzed groups. As it 156 
can be seen in Fig. 3(a), (b) and (c), DC decreases with s when T=1. However, when T increases (Fig. 3(d) to (i)), DC initially 157 
increases and after decreases (for increasing values of s), reaching a stationary state. It should be noticed that, in all cases, 158 
inflection point occurs approximately for s=T; therefore this inflection point is shifted to higher s values when T increases. Given 159 
that, from a certain s value, DC indexes for NRM, LR and HR subjects tend to converge, low values of s (and T) seems to be 160 
more suitable for risk stratification, as it has been said previously. 161 
Responses of DC depending on s value for the simulated data are contained in Fig. 4, for T={1,5,20}. DC calculated from 162 
GWN series (Fig. 4(a)) shows an inflection point where s=T. Previous to the inflection point, DC has an approximately constant 163 
behavior and after DC tends to zero. With regard to DC obtained from ARLFc processes (Fig. 4(b)), a damped oscillatory 164 
behavior that tends to zero is exhibited. It is observed that values of DC are very similar for T=1 and T=5, but they are reduced 165 
for T=20. DC calculated from ARHFc processes showed also a certain damped oscillatory behavior that tends to zero (Fig. 4(c)). 166 
In this case, results are very little dependent on T value. It can be noticed that the response of these HF simulated data is faster 167 
than the response of LF simulation processes. 168 
 169 
3.2 NRM vs. IDC 170 
Table II summarizes temporal, spectral and PRSA indexes from 24h-ECG recordings of healthy group and IDC patients. 171 
When compared to healthy subjects, the pathological group presented a higher meanRR value (p-value=0.044), but a lower 172 
SDNN value (p-value=0.003). On the other hand, LFn and LF/HF were higher in healthy subjects than in IDC patients. 173 
Meanwhile, VLFn was higher in the IDC group (p-value<0.0005). With regard to PRSA indexes, absolute values of AC and DC 174 
were higher in NRM group than in IDC group (p-value<0.0005, sen and spe>60%), which means that acceleration capacities 175 
increase and deceleration capacities decrease, when risk increases. AC[1,3] and DC[1,4] were the ones that provided the highest 176 
sen (83.3%) and spe (74.2% for AC and 71.0% for DC) in discriminating between NRM and IDC groups. For both groups, AC 177 
and DC were asymmetric (p-value<0.001). Indexes AE, DE and AA showed significant p-values. However, classification results 178 
were not better than those provided by AC and DC. In this analysis, AE and DE were higher in the healthy group. Meanwhile, AA 179 
was higher in the IDC group. 180 
Moreover, temporal, spectral and PRSA indexes were obtained from awake and sleep periods of healthy and IDC groups 181 
(Tables III and IV).  182 
When analyzing awake periods (Table III), the pathological group presented lower value of SDNN than healthy subjects (p-183 
value=0.0039). With regard to spectral domain measures of HRV, LFn and LF/HF were higher in healthy subjects than in IDC 184 
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patients; while VLFn and HFn were higher in the IDC group. However, only LF/HF provided sen and spe>60%. Absolute values 185 
of AC and DC were higher in NRM group than in IDC group (p-value<0.0005), as these from 24h-ECG recordings, meaning that 186 
AC increase and DC decrease when risk increases. AC[1,3] and DC[1,3] were the ones that provided the highest sen (90.5% and 187 
88.1%, respectively) and spe (71% and 69.4%, respectively) in discriminating between NRM and IDC groups. In all cases, AC 188 
and DC for both groups were asymmetric (p-value<0.0005). In this analysis, AE and DE were higher in the healthy group (p-189 
value<0.0005, sen and spe>60%). However, classification results were not better than those provided by AC and DC. On the 190 
other hand, there were no significant differences between the areas. 191 
Results from sleep periods are included in Table IV. When compared to healthy subjects, the pathological group presented 192 
lower values of SDNN and HFn and higher value of VLFn. However, none of them provided good classification results (sen and 193 
spe<60%). The remaining temporal and spectral measures showed no significant differences between both groups. With regard 194 
to PRSA indexes, absolute values of AC and DC were higher in NRM group than in IDC group (p-value<0.0005), acceleration 195 
capacities increase and deceleration capacities decrease. AE and DE were significantly higher in the healthy group, as well. 196 
Although these indexes provided high sensitivity, specificity was <60%. Also in this case, AC and DC for both groups (NRM 197 
and IDC) showed asymmetric behavior. 198 
 199 
3.3 LR vs. HR 200 
Table V sums up temporal, frequency-domain and PRSA indexes from 24h-ECG recordings of LR and HR groups. Both 201 
meanRR and SDNN significantly discriminated HR from LR patients (sen and spe>60%). When comparing these two groups of 202 
patients, HR participants presented shorter meanRR and lower SDNN, compared to LR patients. With regard to spectral domain 203 
measures, LFn and LF/HF were higher in the LR group (p-value<0.05, sen and spe>60%), while HFn was higher in the HR 204 
group (p-value<0.005, sen and spe≥60%). Regarding to PRSA indexes, absolute values of AC and DC were higher in LR group 205 
than in HR group, meaning that AC increase and DC decrease when risk increases. AC[3,10] and DC[3,10] were the ones that 206 
provided the best power of classification between LR and HR groups, with sen=83.3% and spe=80%. The asymmetry was 207 
presented between all AC and DC for both groups (from p-value=0.036 to p-value≤0.0005), except for AC[1,2] and DC[1,2] 208 
from the HR group. Results of all AE, DE, AA and DA, except AE[1] and DE[1], showed significant p-values and provided sen 209 
and spe>60%. However, classification results were not better than those provided by AC and DC. In this analysis, AE and DE 210 
and also all the areas of PRSA waveforms were higher in LR group.  211 
For the same forty-two patients, all temporal, spectral and PRSA indexes were calculated from awake and sleep periods 212 
(Tables VI and VII, respectively). 213 
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In analyzing awake periods (Table VI), the LR patients presented significantly higher meanRR and SDNN values, in the 214 
manner of parameters from 24h-ECG recordings. Although both parameters showed significant p-value, only meanRR provided 215 
sen and spe>60%. On the other side, the spectral parameters showed no significant statistical differences between HR and LR 216 
groups from awake periods. Absolute values of AC and DC were higher in LR group (from p-value=0.0117 to p-value<0.005), as 217 
those from 24h-ECG recordings. AC and DC indexes for [T,s]=[1,2] showed very high sen but spe<60%, even though AUC of 218 
these indexes was very high. On the other hand, AC[3,10] and DC[3,10] provided better specificity, but at expense of decreasing 219 
sensitivity. In this analysis, AC and DC for both groups showed asymmetries (p-value<0.05), except for AC[1,2] and DC[1,2] 220 
from the HR group. Results for acceleration and deceleration excursions and PRSA waveforms areas showed significant p-221 
values, except AE and DE for T=1. However, only DA[1] and AA and DA for T=3 provided sen and spe>60%. In this analysis, all 222 
these indexes were higher in the LR group.  223 
With regard to temporal parameters from sleep periods (Table VII), LR patients showed a noticeable higher meanRR and 224 
SDNN (p-value<0.001, sen and spe>60%). In this analysis, LFn was higher in the LR group, while HFn was slightly higher in 225 
the HR group. As it can be seen, although both indexes showed significant p-value, only LFn provided good classification results 226 
(sen and spe>60%). Absolute values of AC and DC were higher in LR group than in HR group, meaning that AC increases and 227 
DC decreases when risk increases. AC and DC for [T,s]=[1,2] and [T,s]=[3,10] provided great classification results between HR 228 
and LR participants, with sensitivities of even 91.7%. In almost all cases, AC and DC for both groups were asymmetric (from p-229 
value=0.041 to p-value≤0.0005), except for AC[3,10] and DC[3,10] from the HR group. All excursions and areas of PRSA 230 
waveforms showed significant p-values. However, only AA and DA for T=1 and T=3 provided sen and spe>60%. In this analysis, 231 
all these indexes were also higher in the LR group. 232 
 233 
4. Discussion 234 
4.1 Methodological Aspects 235 
In this study, the PRSA method proposed by Bauer et al.[13] has been applied to both experimental RR intervals and 236 
simulated data. The advantage of this method is that permits to characterize separately acceleration and deceleration processes of 237 
heart rate, which are supposed to be related to sympathetic and vagal activities, respectively. The purpose of this study was to 238 
analyze acceleration and deceleration processes of beat-to-beat intervals and to try to find significant risk predictors of SCD.  239 
In some cases, it was possible to find values of [T,s] that maximize the statistical classification for both AC and DC. However, 240 
in other cases, different values of [T,s] were necessary to achieve the best predictive power of AC[T,s] and DC[T,s], according 241 
with the concept of asymmetry presented between these two indexes. 242 
 243 
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4.2 PRSA Responses 244 
As it has been shown in this paper, responses of DC depending on s value for the GWN simulated data present an inflection 245 
point where s=T (Fig. 4(a)). This observation suggests that the inflection point is due to the stochastic behavior of the signal. 246 
Since this inflection point is also observed in DC responses obtained from experimental data (Fig. 3), it can be inferred that this 247 
PRSA index includes a certain stochastic component. This stochastic behavior seems to contradict the statement of that PRSA 248 
technique eliminates non-periodic components (artifacts, noise…) from complex signals[13,22].  249 
In Fig. 3(a)-(c), it can be seen a fast response of DC with respect to s and similar to that obtained from ARHFc simulated 250 
processes (Fig. 4(c)). In Bauer et al.[13], it is said that the increase of temporal scale T sets an upper frequency limit for 251 
periodicities that can be detected by PRSA (a kind of low-pass filter). According to this, in the case where T=1, all frequencies of 252 
the signal are taken into account. From these observations, we can conclude that the HF prevails in DC, when T=1. Moreover, 253 
the damped oscillatory behavior of ARHFc is only shown in the analysis of sleep periods, which indicates that HF is more 254 
noticeable during sleep than during awake periods. 255 
However, when T value increases (Fig. 3(d)-(i)), the response of DC calculated from experimental data is slower. This 256 
response is more similar to the behavior of the ARLFc simulated processes (Fig. 4(b)). This fact seems to be in concordance with 257 
Bauer’s statement about the pass-filter effect of increasing T value. This equalizes PRSA responses more in HR group than LR 258 
group and more in awake periods than in sleep periods, indicating an increase of high frequencies from awake to sleep periods. 259 
 260 
4.3 NRM vs.IDC 261 
From 24h-ECG recordings, it was found that some AC, DC, AE and DE discriminated IDC from NRM subjects better than 262 
traditional temporal and frequency measures. Although AC[1,2] provided the best sensitivity, other couples of [T,s], like [1,3] 263 
and [1,4], provided AC and DC indexes, which showed a better spe (>70%) maintaining a very good sen (>80%) in 264 
discriminating NRM from IDC subjects. Statistical classification results from AE and DE were not as good as those from AC and 265 
DC. In addition, these PRSA indexes provided better AUC than all temporal and spectral measures.  266 
It should be noticed that, in all selected PRSA indexes, T value was equal to 1. That means that all periodicities are considered, 267 
since increasing T is like establishing a kind of low-past filter. This optimal T value coincides with the value established in the 268 
work of Kantelhardt et al.[14] as the best [T,s] values for prediction of mortality after heart attack, [T,s]=[1,2]. However, a 269 
slightly increase of the wavelet scale s permits to improve predictive results in this analysis (NRM vs.IDC), as it is shown in 270 
Table II.  271 
Bauer et al.[22] concluded that DC is more powerful predictor of mortality after myocardial infarction than AC. Conversely, 272 
we have found that, between IDC and control subjects, both capacities provide similar predictive power (Table II). Results from 273 
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Kisohara et al.[23] also showed similar predictive values for AC and DC, when predicting mortality after acute myocardial 274 
infarction.  275 
Bauer hypothesis affirms that AC and DC could provide non-invasive measurements of cardiac sympathetic and vagal 276 
modulations, respectively [22]. Evidence of experimental and clinical studies [1,24] indicates that a fall of vagal activity 277 
increases the risk of death. Results obtained here for DC are in agreement with those evidences, since DC is reduced in IDC 278 
patients. However, unlike the results from Bauer et al.[22], results obtained in the present study showed also a significant 279 
increase of AC in pathological subjects. It is believed that sympathetic activity is increased in pathological conditions[21]. Thus, 280 
results of the present study are consistent also with this observation, indicating that AC parameter could reflect the sympathetic 281 
activity, as Bauer stated.  282 
Moreover, it has been verified that AC and DC are correlated with SDNN. Thus, absolute values of AC and DC reflect also 283 
variability of cardiac rhythm. Furthermore, increasing absolute values of PRSA indexes could also reflect a lower ANS 284 
regularity. In their research, Guzik et al.[25] used a distribution function of deceleration and acceleration that was similar to 285 
SDNN2. 286 
It is known that under normal conditions, both branches of the ANS are tonically active when regulating cardiac activity with 287 
a certain dominance of vagal regulation[26]. In general, absolute values of DC and AC are asymmetric, with DC slightly higher 288 
than AC. Since DC is believed to be related to vagal activity, these results are consistent, for healthy subjects, with physiological 289 
observations. These asymmetry results are also consistent with results from previous studies[25,27,28], where it was proved that 290 
the pattern of heart rate during acceleration is different to the pattern of deceleration in normal subjects. Cysarz et al.[29] stated 291 
that sympathetic modulations are slower than parasympathetic modulations captured respectively by acceleration and 292 
deceleration changes of the heart rate of healthy subjects. In our study, some asymmetries have been found between acceleration 293 
and deceleration patterns of IDC patients, as well.  294 
Besides analyzing 24h-ECG recordings from healthy and IDC patients, awake and sleep periods were analyzed. Statistical 295 
results showed that considering only awake periods, predictive power of AC and DC was similar (with little increasing in sen) to 296 
that obtained from 24h-ECG recordings. Also AE and DE calculated from awake periods showed similar predictive results than 297 
those from 24h-ECG recordings. Nevertheless, analysis of sleep periods provided lower specificities (<60%) for AC, DC, AE and 298 
DE than those from 24h recordings and awake periods. In any case, AA and DA were not able to discriminate between NRM and 299 
IDC subjects. 300 
When analyzing awake periods, absolute AC and DC values for both groups were slightly lower than those calculated from 301 
24h recordings. However, these PRSA indexes increased their absolute values when they were calculated from sleep periods. 302 
This agrees with results from Carvajal et al.[30], which showed a higher complexity during the night.  303 
 11
AC values were lower in sleep periods than in awake periods, while DC values were higher in sleep periods, indicating a 304 
decreasing sympathetic activity and an increasing vagal activity during sleep, respectively. Also, certain asymmetry exists 305 
between these |AC| and |DC| values, being the deceleration capacity higher. As it has been said before, deceleration capacity is 306 
supposed to be related to vagal activity, which is predominant during rest. The fact that DC was higher than AC during sleep 307 
periods agrees with that evidence. On the other side, regarding to awake periods, also a certain prevalence of vagal activity 308 
(|DC|>|AC|) was shown, which is consistent with the knowledge of both systems are in equilibrium in normal conditions, with 309 
certain predominance of vagal activity[26]. 310 
 311 
4.4 LR vs. HR 312 
From 24h-ECG recordings, it has been found that AC[1,2], DC[1,2] and SDNN discriminated HR patients from LR patients 313 
with high sensitivity (sen=83.3%) and specificity (spe=70%). For risk stratification of these patients, the increase of T and s 314 
([T,s]=[3,10]) for AC and DC provided improvement in spe to 80%. Most of the AE, DE, AA and DA provided slightly lower 315 
classification results when compared with AC and DC. PRSA indexes were almost as good as SDNN when discriminating HR 316 
from LR patients. However, spectral measures showed lower predictive results.  317 
In the present analysis, HR patients showed an increasing AC and decreasing DC compared with LR patients. Considering that 318 
AC is related to sympathetic modulations and DC to vagal regulation, these results agree with experimental evidence of that 319 
cardiac risk is increased when sympathetic activity increases and/or vagal activity decreases[1,10,24]. As it has been previously 320 
shown, absolute values of AC and DC were higher in LR patients than in HR. This can be interpreted as a lower regularity of the 321 
ANS in LR group. Similar results in post-infarction patients with increased risk of mortality have been reported by other 322 
researches[28], where deceleration was reduced during a two-year follow-up. This observation is in agreement with 323 
physiological evidences, since reduced HRV is associated with higher cardiac risk.  324 
Temporal and spectral measures and PRSA indexes were also analyzed for awake and sleep periods. Statistical results showed 325 
that, considering only awake periods, predictive power of AC and DC were lower than those obtained from 24h-ECG recordings. 326 
Some of the PRSA waveform areas from awake periods provided similar classification results to those from 24h-ECG 327 
recordings. On the other hand, analysis of sleep periods provided better sensitivity, but lower specificity for AC and DC than 328 
those from 24h-ECG recordings and awake periods. 329 
 330 
5. Conclusions 331 
The aim of the present explorative study was to identify essential aspects of the acceleration and deceleration cardiac process 332 
implicated in the heterogeneous etiology of IDC disease. From the analysis of PRSA responses, it was deduced that the inflection 333 
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point observed in the PRSA curves reflects a certain stochastic behavior of the signals. In addition, it can be concluded that the 334 
upper frequencies of the RR series prevail in DC, when T=1, and was more noticeable during sleep than during awake periods. 335 
However, when T value increases, the response of DC calculated from experimental data was slower and more similar to the 336 
behavior of the low frequency oscillations. 337 
AC and DC indexes, mainly for low values of T and s, provided significant discrimination between different risk of SCD 338 
patients, in some cases improving results from traditional temporal and spectral HRV measures. It can be also stated that AC and 339 
DC indexes have permitted to obtain better cardiac risk stratification than using autonomic information flow as in Palacios et 340 
al.[31], analyzing similar myocardial pathology.  341 
Results obtained from PRSA analysis showed a higher AC (which reflects sympathetic activity) and a lower DC (which 342 
reflects vagal activity) in patients with higher risk of cardiac death, which agrees with the fact that the risk of cardiac death is 343 
increased by a growth in sympathetic activity and/or a fall in vagal activity. 344 
Finally, new applications over different pathological populations are necessary to better understand whether AC works slightly 345 
better than DC or this performance is only presented in the analysis of RR series of IDC patients. 346 
 347 
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 573 
 
(a) 
 
(b) 
Fig. 1. (a) Definition of range of acceleration excursion (AE) and the area under the acceleration PRSA waveform (AA); (b) 574 
Definition of range of deceleration excursion (DE) and the area under the deceleration PRSA waveform (DA). 575 
 576 
 577 
 
(a) 
 
 
(b) 
Fig. 2. Color-scale plot of the AUC (area under the ROC curve) for AC (a) and DC (b) depending on T and s values for 24h 578 
recordings when comparing NRM vs. IDC. 579 
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 600 
 601 
 602 
Fig. 3. Behavior of DC depending on s value for T=1 ((a), (b), (c)), T= 5 ((d), (e), (f)), T=20 ((g), (h), (i)) 603 
from 24h recordings, awake periods and sleep periods, respectively. Solid line corresponds to a NRM 604 
subject, dot line to a LR patient and asterisks to a HR patient. 605 
 606 
 607 
 608 
 
(a) (b) (c) 
Fig. 4. Behavior of DC depending on s value for T=1 (solid line), T=5 (dot line), T=20 (asterisks) from 609 
different simulated series: (a) GWN, (b) ARLFc and (c) ARHFc. 610 
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 622 
TABLE I 623 
PATIENT DEMOGRAPHIC CHARACTERISTICS, BASELINE CLINICAL STATUS AND TREATMENTS 624 
 NRM LR HR 
N (subjects) 62 30 12 
Age (years, mean ± SD) 36.2±17.0 51.8±13.3 48.3±13.1 
Female sex 36 (58.1%) 5 (16.7%) 1 (8.3%) 
Etiology    
      VT 0 (0.0%) 12 (40.0%) 4 (33.3%) 
      LVEF  26.2% 17.6% 
Co-morbidities    
      Hypertension 1 (1.6%) 11 (36.7%) 0 (0.0%) 
      Diabetes Mellitus 0 (0.0%) 3 (10.0%) 2 (16.7%) 
Therapy    
      Digoxin 0 (0.0%) 9 (30.0%) 9 (75.0%) 
      Beta-blockers 0 (0.0%) 8 (26.7%) 2 (16.7%) 
      ACE inhibitors 1 (1.6%) 27 (90.0%) 11 (91.7%) 
      Antiarrhythmics  0 (0.0%) 17 (56.7%) 2 (16.7%) 
      Diuretics 0 (0.0%) 12 (40.0%) 8(66.7%) 
      LVEF, left ventricular ejection fraction; VT, ventricular tachycardia. 625 
 626 
 627 
 628 
 629 
 630 
TABLE II 631 
RR INTERVALS OF 24H-ECG RECORDINGS FROM HEALTHY (NRM) AND IDC SUBJECTS 632 
 NRM mean±std 
IDC 
mean±std 
Sen 
(%) 
Spe 
(%) AUC 
N (subjs.) 62 42    
meanRR  773.6±98.8 783.7±103.9* 28.6 77.4 0.558 
SDNN  146.7±49.2 118.8±46.5** 71.4 58.1 0.672 
VLFn  31.59±4.24 34.32±6.47‡ 52.4 82.3 0.668 
LFn  48.25±7.08 41.31±8.82‡ 54.8 74.2 0.711 
HFn  42.65±5.96 44.37±5.56† - - - 
LF/HF 1.23±0.38 1.01±0.34* 61.9 45.2 0.652 
AC[1,2] -12.88±4.78 -6.97±3.17‡ 85.7 67.7 0.844 
DC[1,2] 13.32±4.86 7.38±3.46‡ 78.6 66.1 0.834 
AC[1,3] -10.60±3.23 -5.78±2.61‡ 83.3 74.2 0.871 
DC[1,3] 11.09±3.46 6.15±2.82‡ 81.0 71.0 0.858 
AC[1,4] -9.54±3.05 -5.23±2.99‡ 83.3 72.6 0.854 
DC[1,4] 10.05±3.27 5.58±2.79‡ 83.3 71.0 0.848 
AE[1] 30.76±12.75 21.99±13.35‡ 76.2 61.3 0.745 
DE[1] 31.94±12.79 23.16±14.54‡ 73.8 67.7 0.741 
AA[1]*104 23.30±3.00 23.60±3.13* 31.0 75.8 0.560 
DA[1]*104 23.36±2.94 23.62±3.13† - - - 
meanRR, SDNN, AC, DC, AE and DE expressed in ms. VLFn, LFn and  HFn expressed in n.u. AA and 633 
DA expressed in area units. ‡p-value<0.0005, **p-value<0.005, *p-value<0.05, †p-value=n.s. 634 
 635 
 636 
 637 
 638 
 639 
 640 
 641 
 642 
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 643 
 644 
 645 
 646 
 647 
TABLE III 648 
RR INTERVALS OF AWAKE PERIODS OF ECG RECORDINGS FROM HEALTHY (NRM) AND IDC SUBJECTS 649 
 NRM mean±std 
IDC 
mean±std 
Sen 
(%) 
Spe 
(%) 
AUC 
N (subjs.) 62 42    
meanRR  700.8±93.2 721.9±96.3† - - - 
SDNN  85.8±26.4 73.0±30.4** 57.1 59.7 0.661 
VLFn  32.07±4.39 34.85±6.91‡ 57.1 75.8 0.668 
LFn  51.08±7.44 41.68±11.01‡ 57.1 80.7 0.753 
HFn  39.59±6.05 42.96±6.65* 50.0 69.4 0.648 
LF/HF 1.38±0.42 1.07±0.45‡ 61.9 69.4 0.589 
AC[1,2]  -10.98±4.72 -5.88±3.18‡ 83.3 62.9 0.834 
DC[1,2]  11.42±4.53 6.32±3.51‡ 81.0 66.1 0.825 
AC[1,3]  -10.23±3.79 -5.06±2.76‡ 90.5 71.0 0.854 
DC[1,3]  10.82±3.98 5.49±3.04‡ 88.1 69.4 0.848 
AE[1]  27.34±12.04 19.61±12.67‡ 78.6 67.7 0.733 
DE[1]  28.71±11.73 20.83±13.84‡ 76.2 64.5 0.734 
AA[1]*104 21.00±2.77 21.65±2.87† - - - 
DA[1]*104 21.07±2.80 21.66±2.86† - - - 
meanRR, SDNN, AC, DC, AE and DE expressed in ms. VLFn, LFn and  HFn expressed in n.u. AA and DA 650 
expressed in area units. ‡p-value<0.0005, **p-value<0.005, *p-value<0.05, †p-value=n.s. 651 
 652 
 653 
 654 
 655 
TABLE IV 656 
RR INTERVALS OF SLEEP PERIODS OF ECG RECORDINGS FROM HEALTHY (NRM) AND IDC SUBJECTS 657 
 NRM mean±std 
IDC 
mean±std 
Sen 
(%) 
Spe 
(%) 
AUC 
N (subjs.) 62 42    
meanRR  953.6±158.0 907.9±148.8† - - - 
SDNN  97.0±34.4 82.8±40.3* 45.2 62.9 0.631 
VLFn  29.51±5.65 32.94±6.96‡ 52.4 80.7 0.671 
LFn  44.90±8.53 41.51±8.90† - - - 
HFn  46.45±7.70 45.43±6.09* 71.4 46.8 0.564 
LF/HF 1.06±0.43 0.99±0.34† - - - 
AC[1,2]  -17.36±7.86 -9.40±4.71‡ 83.3 56.5 0.806 
DC[1,2]  18.11±8.80 9.88±5.16‡ 85.7 53.2 0.802 
AE[1]  43.57±23.59 28.59±16.39§ 85.7 45.2 0.716 
DE[1]  45.73±26.70 30.01±17.55* 90.5 37.1 0.700 
AA[1]*104 28.54±4.74 27.19±4.46† - - - 
DA[1]*104 28.57±4.72 27.18±4.44† - - -
meanRR, SDNN, AC, DC, AE and DE expressed in ms. VLFn, LFn and  HFn expressed in n.u. AA and 658 
DA expressed in area units. ‡p-value<0.0005, §p-value<0.001, *p-value<0.05, †p-value=n.s. 659 
 660 
 661 
 662 
 663 
 664 
 665 
 666 
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TABLE V 673 
RR INTERVALS OF 24H-ECG RECORDINGS FROM LR AND HR PATIENTS 674 
 LR mean±std 
HR 
mean±std 
Sen 
(%) 
Spe 
(%) 
AUC 
N (subjs.) 30 12    
meanRR  816.0±94.9 702.9±80.6§ 66.7 76.7 0.839 
SDNN  132.7±46.4 84.0±23.7‡ 83.3 70.0 0.861 
VLFn   34.04±7.12 35.05±4.66† - - - 
LFn   42.40±9.80 38.58±5.07* 75.0 70.0 0.639 
HFn    44.22±6.22 44.74±3.63** 66.7 60.0 0.558 
LF/HF 1.05±0.37 0.91±0.20* 75.0 63.3 0.586 
AC[1,2]  -8.00±3.06 -4.41±1.64‡ 83.3 70.0 0.858 
DC[1,2]  8.52±3.35 4.53±1.56‡ 83.3 70.0 0.861 
AC[3,10]  -8.45±2.57 -5.49±2.10** 83.3 80.0 0.819 
DC[3,10]  8.98±2.82 5.78±2.31** 83.3 80.0 0.811 
AE[1]  24.64±14.85 15.36±4.02† - - - 
DE[1]  26.17±16.11 15.65±4.28† - - - 
AA[1]*104 24.58±2.86 21.15±2.41§ 66.7 76.7 0.839 
DA[1]*104 24.61±2.86 21.16±2.40§ 66.7 80.0 0.847 
AE[3]  25.97±9.99 16.09±5.71** 83.3 63.3 0.817 
DE[3]  27.57±10.77 16.78±6.02** 83.3 63.3 0.828 
AA[3]*104 24.43±2.85 21.07±2.39§ 66.7 76.7 0.836 
DA[3]*104 24.48±2.82 21.10±2.42§ 66.7 76.7 0.836 
meanRR, SDNN, AC, DC, AE and DE expressed in ms. VLFn, LFn and  HFn expressed in n.u. AA and DA 675 
expressed in area units. ‡p-value<0.0005, §p-value<0.001, **p-value<0.005, *p-value<0.05,  676 
†p-value=n.s. 677 
 678 
 679 
 680 
 681 
TABLE VI 682 
RR INTERVALS OF AWAKE PERIODS OF ECG RECORDINGS FROM LR AND HR PATIENTS 683 
 LR mean±std 
HR 
mean±std 
Sen 
(%) 
Spe 
(%) 
AUC 
N (subjs.) 30 12
meanRR  749.5±94.4 652.8±61.3** 83.3 60.0 0.839 
SDNN  80.1±31.5 55.2±18.7* 83.3 50.0 0.767 
VLFn  34.21±7.58 36.44±4.73† - - - 
LFn  42.99±11.82 38.42±8.22† - - - 
HFn  42.49±7.27 44.16±4.84† - - - 
LF/HF 1.12±0.49 0.92±0.28† - - - 
AC[1,2]  -6.72±3.29 -3.80±1.65** 83.3 56.7 0.811 
DC[1,2]  7.28±3.62 3.95±1.64* 83.3 53.3 0.817 
AC[3,10]  -7.13±2.57 -4.79±2.07* 66.7 63.3 0.758 
DC[3,10]  7.67±2.80 5.10±2.37* 66.7 66.7 0.753 
AE[1]  21.97±14.23 13.71±3.34† - - - 
DE[1]  23.56±15.47 13.99±3.44† - - - 
AA[1]*104 22.47±2.81 19.59±1.84** 83.3 56.7 0.833 
DA[1]*104 22.48±2.80 19.59±1.85** 83.3 60.0 0.836 
AE[3]  22.31±10.49 14.39±4.96* 83.3 50.0 0.769 
DE[3]  23.93±11.56 14.92±5.25* 75.0 50.0 0.783 
AA[3]*104 22.41±2.81 19.54±1.83** 83.3 60.0 0.842 
DA[3]*104 22.44±2.81 19.56±1.84** 83.3 60.0 0.833 
meanRR, SDNN, AC, DC, AE and DE expressed in ms. VLFn, LFn and  HFn expressed in n.u. AA and DA 684 
expressed in area units. **p-value<0.005, *p-value<0.05, †p-value=n.s. 685 
 686 
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 687 
 688 
 689 
TABLE VII 690 
RR INTERVALS OF SLEEP PERIODS OF ECG RECORDINGS FROM LR AND HR PATIENTS 691 
 LR mean±std 
HR 
mean±std 
Sen 
(%) 
Spe 
(%) 
AUC 
N (subjs.) 30 12    
meanRR  957.0±136.2 785.3±103.2‡ 66.7 80.0 0.867 
SDNN  93.2±42.5 57.0±16.6§ 75.0 66.7 0.797 
VLFn  33.29±7.65 32.08±5.02† - - - 
LFn  42.85±9.52 38.16±6.29* 83.3 60.0 0.650 
HFn  45.33±6.54 45.68±5.05* 75.0 36.7 0.544 
LF/HF 1.03±0.36 0.89±0.27† - - - 
AC[1,2]  -10.79±4.73 -5.92±2.27‡ 83.3 60.0 0.844 
DC[1,2]  11.44±5.25 6.00±1.91** 83.3 63.3 0.850 
AC[3,10]  -11.40±4.55 -7.05±3.08** 91.7 66.7 0.789 
DC[3,10]  12.06±4.96 7.34±3.26** 91.7 66.7 0.783 
AE[1]  32.17±17.78 19.63±6.77* 91.7 40.0 0.756 
DE[1]  34.06±18.79 19.91±7.80* 83.3 43.3 0.772 
AA[1]*104 28.67±4.09 23.51±3.08‡ 66.7 80.0 0.867 
DA[1]*104 28.64±4.06 23.52±3.07‡ 66.7 80.0 0.867 
AE[3]  35.97±14.48 22.58±7.98** 91.7 56.7 0.783 
DE[3]  38.07±15.39 23.42±8.48** 91.7 56.7 0.799 
AA[3]*104 28.62±4.09 23.49±3.08‡ 66.7 80.0 0.867 
DA[3]*104 28.63±4.08 23.50±3.09‡ 66.7 80.0 0.867 
meanRR, SDNN, AC, DC, AE and DE expressed in ms. VLFn, LFn and  HFn expressed in n.u. AA and DA 692 
expressed in area units. ‡p-value<0.0005, §p-value<0.001, **p-value<0.005, *p-value<0.05, †p-693 
value=n.s. 694 
 695 
 696 
 697 
